RxSight, Inc. (RXST) Tops Q3 EPS by 24c

RxSight, Inc. (NASDAQ: RXST) reported Q3 EPS of ($0.19), $0.24 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20.55 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Redwood Trust prices $185M convertible notes due 2030
• RUM Group to raise Northern Data stake to ~98% via share purchase